Psychedelic Drugs Market Report 2026
Download Free Sample Buy Now
Psychedelic Drugs Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Psychedelic Drugs Market Report 2026

Global Outlook – By Type (Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia), By Disease Indication (Depression, PTSD), By Origin (Natural, Synthetic), By Application (Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Psychedelic Drugs Market Overview

• Psychedelic Drugs market size has reached to $6.33 billion in 2025

• Expected to grow to $13.67 billion in 2030 at a compound annual growth rate (CAGR) of 16.7%

• Growth Driver: Surging Cases Of Mental Illness To Drive Market Growth

• Market Trend: Advancements In Therapeutic Psilocybin Formulations

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Psychedelic Drugs Market?

Psychedelic drug refers to a group of psychoactive drugs that alter perception, mood, and thought processes. All the senses are affected by psychedelics, which change a person's thinking, perception of time, and emotions. These include chemicals such as Lysergic acid diethylamide (LSD) and plants such as peyote. These medications are used to treat a variety of brain conditions.

The main types of psychedelic drugs are lysergic acid diethylamide, ketamine, phencyclidine, gamma-hydroxybutyric acid (GHB), and salvia. Lysergic Acid Diethylamide (LSD) is also known colloquially as acid. LSD is manufactured in crystalline form and then mixed with other inert ingredients or diluted as a liquid to produce an ingestible form. The various disease indications include depression and PTSD, which could be natural or synthetic. The numerous applications include treatment-resistant depression, opiate addiction, post-traumatic stress disorder, narcolepsy, and panic disorders, and are distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

Psychedelic Drugs Market Global Report 2026 Market Report bar graph

What Is The Psychedelic Drugs Market Size and Share 2026?

The psychedelic drugs market size has grown rapidly in recent years. It will grow from $6.33 billion in 2025 to $7.37 billion in 2026 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to high unmet need in depression treatment, early academic research on psychedelics, underground and compassionate use cases, limited efficacy of conventional antidepressants, rising mental health awareness.

What Is The Psychedelic Drugs Market Growth Forecast?

The psychedelic drugs market size is expected to see rapid growth in the next few years. It will grow to $13.67 billion in 2030 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to regulatory approvals for medical use, growing psychiatrist adoption, expansion of indication pipeline, improved patient outcomes data, strategic partnerships between biotech and healthcare providers. Major trends in the forecast period include expansion of psychedelic-assisted therapy programs, increasing clinical trials for mental health indications, growing acceptance of alternative psychiatry treatments, regulatory pathway clarification for controlled substances, rising investment from venture capital and pharma players.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Psychedelic Drugs Market Segmentation

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

What Is The Driver Of The Psychedelic Drugs Market?

The increase in the cases of mental illnesses is expected to propel the growth of the psychedelic drugs market going forward. Mental illnesses refer to health conditions involving changes in emotion, thinking, or behavior. Mental illnesses include conditions such as distress and post-traumatic stress disorder. Psychedelic drugs are used to treat depression and post-traumatic stress disorder, and their regular usage decreases mental illnesses. For instance, in November 2023, according to the National Health Service, a UK-based government department, in 2023, approximately one in five individuals aged 8 to 25 years were estimated to have a probable mental disorder, affecting 20.3% of 8 to 16-year-olds, 23.3% of 17 to 19-year-olds, and 21.7% of 20 to 25-year-olds. Therefore, an increase in the number of cases of mental illnesses is driving the growth of the psychedelic drugs industry.

Key Players In The Global Psychedelic Drugs Market

Major companies operating in the psychedelic drugs market are Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

Global Psychedelic Drugs Market Trends and Insights

Major companies operating in the psychedelic drugs market are focusing on developing innovative solutions such as pharmaceutical-grade psilocybin formulations to enhance therapeutic efficacy, ensure safety, and expand treatment options for mental health disorders. Grade psilocybin formulation refers to psilocybin produced and standardized to pharmaceutical-grade quality, ensuring consistent purity, potency, and safety for therapeutic use. For instance, in September 2025, Optimi Health, an Australia-based psychedelic therapeutics company, launched its natural psilocybin capsules in Australia for the treatment of TRD. With this launch, Optimi Health aims to provide a clinically supported treatment option for patients, expand its presence in the Australian mental health market, and accelerate the adoption of psychedelic-assisted therapies.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Psychedelic Drugs Market?

In October 2023, Cybin Inc., a Canada-based psychedelic therapeutics company, completed the acquisition of Small Pharma Inc., for an undisclosed amount. With this acquisition, Cybin aims to create an international clinical-stage leader in novel psychedelic therapeutics, expand its pipeline of psilocybin-based treatments, accelerate clinical development, and enhance its research and commercialization capabilities. Small Pharma Inc. is a UK-based clinical-stage biotechnology company focused on developing innovative psychedelic therapies for mental health disorders.

Regional Insights

North America was the largest region in the psychedelic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Psychedelic Drugs Market?

The psychedelic drugs market consists of sales of psilocybin, PCP, cannabis, and ecstasy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Psychedelic Drugs Market Report 2026?

The psychedelic drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the psychedelic drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Psychedelic Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $7.37 billion
Revenue Forecast In 2035 $13.67 billion
Growth Rate CAGR of 16.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Disease Indication, Origin, Application, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Heal
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Psychedelic Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Psychedelic Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Psychedelic Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Psychedelic Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Healthcare Innovation & Advanced Therapeutics

4.2. Major Trends

4.2.1 Expansion Of Psychedelic-Assisted Therapy Programs

4.2.2 Increasing Clinical Trials For Mental Health Indications

4.2.3 Growing Acceptance Of Alternative Psychiatry Treatments

4.2.4 Regulatory Pathway Clarification For Controlled Substances

4.2.5 Rising Investment From Venture Capital And Pharma Players

5. Psychedelic Drugs Market Analysis Of End Use Industries

5.1 Hospitals And Specialty Clinics

5.2 Psychiatric Treatment Centers

5.3 Rehabilitation And Addiction Treatment Centers

5.4 Research And Academic Institutes

5.5 Mental Health Specialty Clinics

6. Psychedelic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Psychedelic Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Psychedelic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Psychedelic Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Psychedelic Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Psychedelic Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Psychedelic Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Psychedelic Drugs Market Segmentation

9.1. Global Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

9.2. Global Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Depression, PTSD

9.3. Global Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Natural, Synthetic

9.4. Global Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

9.5. Global Psychedelic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

9.6. Global Psychedelic Drugs Market, Sub-Segmentation Of Lysergic Acid Diethylamide (LSD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

LSD Tablets, LSD Liquid, LSD Blotters

9.7. Global Psychedelic Drugs Market, Sub-Segmentation Of Ketamine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

9.8. Global Psychedelic Drugs Market, Sub-Segmentation Of Phencyclidine (PCP), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

PCP Powder, PCP Tablets, PCP Liquid

9.9. Global Psychedelic Drugs Market, Sub-Segmentation Of Gamma Hydroxybutyric Acid (GHB), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

GHB Liquid, GHB Powder, GHB Capsules

9.10. Global Psychedelic Drugs Market, Sub-Segmentation Of Salvia, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

10. Psychedelic Drugs Market Regional And Country Analysis

10.1. Global Psychedelic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Psychedelic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Psychedelic Drugs Market

11.1. Asia-Pacific Psychedelic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Psychedelic Drugs Market

12.1. China Psychedelic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Psychedelic Drugs Market

13.1. India Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Psychedelic Drugs Market

14.1. Japan Psychedelic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Psychedelic Drugs Market

15.1. Australia Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Psychedelic Drugs Market

16.1. Indonesia Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Psychedelic Drugs Market

17.1. South Korea Psychedelic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Psychedelic Drugs Market

18.1. Taiwan Psychedelic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Psychedelic Drugs Market

19.1. South East Asia Psychedelic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Psychedelic Drugs Market

20.1. Western Europe Psychedelic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Psychedelic Drugs Market

21.1. UK Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Psychedelic Drugs Market

22.1. Germany Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Psychedelic Drugs Market

23.1. France Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Psychedelic Drugs Market

24.1. Italy Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Psychedelic Drugs Market

25.1. Spain Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Psychedelic Drugs Market

26.1. Eastern Europe Psychedelic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Psychedelic Drugs Market

27.1. Russia Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Psychedelic Drugs Market

28.1. North America Psychedelic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Psychedelic Drugs Market

29.1. USA Psychedelic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Psychedelic Drugs Market

30.1. Canada Psychedelic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Psychedelic Drugs Market

31.1. South America Psychedelic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Psychedelic Drugs Market

32.1. Brazil Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Psychedelic Drugs Market

33.1. Middle East Psychedelic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Psychedelic Drugs Market

34.1. Africa Psychedelic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Psychedelic Drugs Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Psychedelic Drugs Market Regulatory and Investment Landscape

36. Psychedelic Drugs Market Competitive Landscape And Company Profiles

36.1. Psychedelic Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Psychedelic Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Psychedelic Drugs Market Company Profiles

36.3.1. Atai Life Sciences Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Cybin Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Mind Medicine Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Compass Pathways Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Seelos Therapeutics Overview, Products and Services, Strategy and Financial Analysis

37. Psychedelic Drugs Market Other Major And Innovative Companies

Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation

38. Global Psychedelic Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Psychedelic Drugs Market

40. Psychedelic Drugs Market High Potential Countries, Segments and Strategies

40.1 Psychedelic Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Psychedelic Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Psychedelic Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Psychedelic Drugs Market, Overview Of Key Products - Product Examples
  • Table 2: Global Psychedelic Drugs Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Psychedelic Drugs Market, Supply Chain Analysis
  • Table 4: Global Psychedelic Drugs Market, Major Raw Material Providers
  • Table 5: Global Psychedelic Drugs Market, Major Resource Providers
  • Table 6: Global Psychedelic Drugs Market, Major Manufacturers (Suppliers)
  • Table 7: Global Psychedelic Drugs Market, Major Distributors And Channel Partners
  • Table 8: Global Psychedelic Drugs Market, Key Technologies & Future Trends
  • Table 9: Global Psychedelic Drugs Market, Major Trends
  • Table 10: Global Psychedelic Drugs Market, Major End Users
  • Table 11: Global Psychedelic Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Psychedelic Drugs Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Psychedelic Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Psychedelic Drugs Market - TAM, US$ Billion, 2025
  • Table 15: Global Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Psychedelic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Psychedelic Drugs Market, Sub-Segmentation Of Lysergic Acid Diethylamide (LSD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Psychedelic Drugs Market, Sub-Segmentation Of Ketamine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Psychedelic Drugs Market, Sub-Segmentation Of Phencyclidine (PCP), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Psychedelic Drugs Market, Sub-Segmentation Of Gamma Hydroxybutyric Acid (GHB), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Psychedelic Drugs Market, Sub-Segmentation Of Salvia, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Psychedelic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Psychedelic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Psychedelic Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Psychedelic Drugs Market - Company Scoring Matrix
  • Table 101: Atai Life Sciences Financial Performance
  • Table 102: Cybin Inc. Financial Performance
  • Table 103: Mind Medicine Inc. Financial Performance
  • Table 104: Compass Pathways Financial Performance
  • Table 105: Seelos Therapeutics Financial Performance
  • Table 106: Global Psychedelic Drugs Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global Psychedelic Drugs Market, Competitive Dashboard
  • Table 108: Global Psychedelic Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, Psychedelic Drugs Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 110: Global, Psychedelic Drugs Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030
  • Table 111: Global, Psychedelic Drugs Market Size Gain ($ Billion), Segmentation By Origin, 2025 – 2030

List Of Figures

    Figure 1: Global Psychedelic Drugs Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Psychedelic Drugs Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Psychedelic Drugs Market, Supply Chain Analysis
  • Figure 4: Global Psychedelic Drugs Market, Major Raw Material Providers
  • Figure 5: Global Psychedelic Drugs Market, Major Resource Providers
  • Figure 6: Global Psychedelic Drugs Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Psychedelic Drugs Market, Major Distributors And Channel Partners
  • Figure 8: Global Psychedelic Drugs Market, Key Technologies & Future Trends
  • Figure 9: Global Psychedelic Drugs Market, Major Trends
  • Figure 10: Global Psychedelic Drugs Market, Major End Users
  • Figure 11: Global Psychedelic Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Psychedelic Drugs Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Psychedelic Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Psychedelic Drugs Market - TAM, US$ Billion, 2025
  • Figure 15: Global Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Psychedelic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Psychedelic Drugs Market, Sub-Segmentation Of Lysergic Acid Diethylamide (LSD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Psychedelic Drugs Market, Sub-Segmentation Of Ketamine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Psychedelic Drugs Market, Sub-Segmentation Of Phencyclidine (PCP), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Psychedelic Drugs Market, Sub-Segmentation Of Gamma Hydroxybutyric Acid (GHB), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Psychedelic Drugs Market, Sub-Segmentation Of Salvia, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Psychedelic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Psychedelic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Psychedelic Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Psychedelic Drugs Market - Company Scoring Matrix
  • Figure 101: Atai Life Sciences Financial Performance
  • Figure 102: Cybin Inc. Financial Performance
  • Figure 103: Mind Medicine Inc. Financial Performance
  • Figure 104: Compass Pathways Financial Performance
  • Figure 105: Seelos Therapeutics Financial Performance
  • Figure 106: Global Psychedelic Drugs Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global Psychedelic Drugs Market, Competitive Dashboard
  • Figure 108: Global Psychedelic Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, Psychedelic Drugs Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 110: Global, Psychedelic Drugs Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030
  • Figure 111: Global, Psychedelic Drugs Market Size Gain ($ Billion), Segmentation By Origin, 2025 – 2030

$6.46 Billion Forecast for Peptide Drug Conjugates Market by 2029, Backed by Demand and Innovation

Read More About $6.46 Billion Forecast for Peptide Drug Conjugates Market by 2029, Backed by Demand and Innovation

Personalized Dietary Supplements Market Forecast Reaching $14.17 Billion by 2029 at 10.9% CAGR

Read More About Personalized Dietary Supplements Market Forecast Reaching $14.17 Billion by 2029 at 10.9% CAGR

Personalized Vitamin Products Market Valuation Expected To Reach $18.06 Billion By 2029, Growing At A Rate Of 13.6%

Read More About Personalized Vitamin Products Market Valuation Expected To Reach $18.06 Billion By 2029, Growing At A Rate Of 13.6%

Strong CAGR to Propel in the Personalized Vitamins Market and Beyond upto $10.75 Billion by 2029

Read More About Strong CAGR to Propel in the Personalized Vitamins Market and Beyond upto $10.75 Billion by 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Central Nervous System Drugs Global Market Report 2022 – By Type (Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route O...

Alzheimer's Drugs Market Report 2026 - Global Outlook – By Drugs (Donepezil, Rivastigmine, Galantamine, Memantine ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By Application (Early T...

Narcotic Drugs Market Report 2026 - Global Outlook – By Drug (Opium, Heroin, Codeine, Oxycodone, Other Drugs), By Source (Natural, Semi-Synthetic, Synthetic), By Indication (Pain Management, Cough, Diarrhea, Dysentery, O...

Nicotine Addiction Treatment Market Report 2026 - Global Outlook – By Type (Pharmacological, Therapies, Other Types ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By End-User (Generati...

Psychedelic Drugs Market Report 2026 - Global Outlook – By Type (Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia), By Disease Indication (Depression, PTSD), By Origin (N...

Neurological Disorder Drugs Market Report 2026 - Global Outlook – By Drug Class (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor Antagonists, Antiepileptic, Antipsychotic And Antidepressant, Other Drugs C...

Antipsychotic Drugs Market Report 2026 - Global Outlook – By Therapeutic Class (First Generation, Second Generation, Third Generation), By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Di...

Inhalable Drugs Market Report 2026 - Global Outlook – By Product (Aerosol, Dry Powder Formulation, Spray), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Other Distribution Channels), By Application (Respir...

Frequently Asked Questions

The Psychedelic Drugs Market Report 2026 market was valued at $6.33 billion in 2025, increased to $7.37 billion in 2026, and is projected to reach $13.67 billion by 2030. request a sample here

The expected CAGR for the Psychedelic Drugs Market Report 2026 market during the forecast period 2025–2030 is 16.7%. request a sample here

Major growth driver of the market includes: Surging Cases Of Mental Illness To Drive Market Growth in the Psychedelic Drugs Market Report 2026 market. For further insights on this market, request a sample here

The psychedelic drugs market covered in this report is segmented –
1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia
2) By Disease Indication: Depression, PTSD
3) By Origin: Natural, Synthetic
4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders
5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy Subsegments:
1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters
2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable
3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid
4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules
5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures request a sample here

Major trend in this market includes: Advancements In Therapeutic Psilocybin Formulations For further insights on this market, request a sample here.

Major companies operating in the Psychedelic Drugs Market Report 2026 market are Major companies operating in the psychedelic drugs market are Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness I request a sample here.

North America was the largest region in the psychedelic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us